Live Breaking News & Updates on Wilm tumor

Stay informed with the latest breaking news from Wilm tumor on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Wilm tumor and stay connected to the pulse of your community

Cue Biopharma to Present at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting

BOSTON, April 24, 2024 -- Cue Biopharma, Inc. , a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selectively modulate disease-specific T cells,...

Chicago , Illinois , United-states , Boston , Massachusetts , Wisconsin , American , Marie-campinell , Nataliya-uboha , Douglasr-atkins , Jonathan-pappas , Lifesci-communications

Cue Biopharma Reports Fourth Quarter and Full Year 2023 Financial Results and Updated Business Highlights

BOSTON, April 08, 2024 -- Cue Biopharma, Inc. , a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selectively modulate disease-specific T cells, today...

Boston , Massachusetts , United-states , Jonathan-pappas , Marie-campinell , Daniel-passeri , Corporate-communications , Lifesci-communications , Society-for-immunotherapy , Drug-administration , Nasdaq , Cue-biopharma-inc

Cue Biopharma Reports Fourth Quarter and Full Year 2023 Financial Results and Updated Business Highlights

Cue Biopharma Reports Fourth Quarter and Full Year 2023 Financial Results and Updated Business Highlights
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Boston , Massachusetts , United-states , Jonathan-pappas , Daniel-passeri , Marie-campinell , Cue-biopharma-inc , Linkedin , Nasdaq , Society-for-immunotherapy , Drug-administration , Corporate-communications

Cue Biopharma Presents New Positive Data from Phase 1 Trials of CUE-101 in Head and Neck Cancer and CUE-102 in Wilms' Tumor 1 Positive Cancers at SITC 2023 -November 03, 2023 at 12:01 pm EDT

Overall response rate of 47% and disease control rate of 65% in first line recurrent/metastatic HNSCC patients treated with CUE-101 and KEYTRUDA® ORR of 56% in patients with low expression of...

Boston , Massachusetts , United-states , California , San-diego , Dan-passeri , Matteo-levisetti , Jennifer-eva-selfridge , Maya-romanchuk , Christine-chung , Marie-campinell , Lifesci-communications

Cue Biopharma Announces Completion of Patient Enrollment in Phase 1b Study of CUE-101 in Combination with KEYTRUDA®

Completed enrollment of patient expansion cohort of 20 patients at the RP2D of 4 mg/kg in combination with KEYTRUDA® (pembrolizumab) in first line...

Boston , Massachusetts , United-states , Maya-romanchuck , Matteo-levisetti , Marie-campinell , Daniel-passeri , Corporate-communications , Securities-exchange , Cue-biopharma-inc , Society-for-immunotherapy-of-cancer , Nasdaq

New kidney tissue model could help assess safety of immunotherapy drugs

A growing repertoire of cell and molecule-based immunotherapies is offering patients with indomitable cancers new hope by mobilizing their immune systems against tumor cells.

Boston , Massachusetts , United-states , Munich , Bayern , Germany , Switzerland , Ken-hiratsuka , Virginie-micallef , Alejandro-carpy , Antje-christine-walz , Jennifer-lewi

Adding immunity to human kidney-on-a-chip advances cancer drug testing

Adding immunity to human kidney-on-a-chip advances cancer drug testing
sciencedaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sciencedaily.com Daily Mail and Mail on Sunday newspapers.

Boston , Massachusetts , United-states , Munich , Bayern , Germany , Switzerland , Marcel-gruber , Mariana-mata , Ryuji-morizane , Annie-moisan , Ken-hiratsuka

Adding immunity to human kidney-on-a-chip adv

T cell bispecific antibodies (TCBs) are an emerging class of immunotherapeutics with several TCBs approved by the FDA for the treatment of leukemias, lymphomas, and myelomas. TCBs label tumor cells with one of their ends, and attract immune cells with another end to coerce them into tumor cell killing. However, one major challenge in the development of TCBs are “on-target, off-tumor” toxicities at sites in the body that also express TCB-targeted antigens. A new collaboration of Jennifer Lewis’ group and researchers from the Roche Innovation Centers in Switzerland and Germany now created an immune-infiltrated human kidney organoid-on-chip model that allows kidney toxicity of TCBs.

Boston , Massachusetts , United-states , Spaulding-rehabilitation-hospital , Tufts-university , Switzerland , Massachusetts-institute-of-technology , Germany , Munich , Bayern , University-of-massachusetts-medical-school , Boston-university

Adding immunity to human kidney-on-a-chip advances cancer drug testing

Adding immunity to human kidney-on-a-chip advances cancer drug testing
medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.

Germany , Switzerland , Ryuji-morizane , Kimberly-homan , Joseph-bonventre , Katharina-kroll , Jennifer-lewi , Jennifer-lewis , Donald-ingber , Katharinat-kroll , Drug-administration , D-organ-engineering-initiative

Adding immunity to human kidney-on-a-chip adv

Adding immunity to human kidney-on-a-chip adv
eurekalert.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from eurekalert.org Daily Mail and Mail on Sunday newspapers.

Boston , Massachusetts , United-states , Massachusetts-institute-of-technology , University-of-massachusetts-medical-school , Switzerland , Spaulding-rehabilitation-hospital , Boston-university , Munich , Bayern , Germany , Berlin